Release 5 FHIR CI-Build

This page is part of the Continuous Integration Build of FHIR Specification (v5.0.0: R5 - STU ). This is the current published version in it's permanent home (it will always (will be available incorrect/inconsistent at this URL). For a full list of available versions, see times).
See the Directory of published versions . Page versions: R5 R4B R4 R3

Example MedicationRequest/medrx0317 (Narrative)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Standards Status : Informative Compartments : Encounter , Group , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationRequest .

Generated Narrative: MedicationRequest medrx0317

Resource MedicationRequest "medrx0317"

identifier : id: 12345689 (use: OFFICIAL) http://www.bmc.nl/portal/prescriptions /12345689 (use: official, )

status : completed Completed

intent : order Order

Medications

- Reference
* code : Alemtuzumab 10mg/ml (Lemtrada) ( RxNorm Medication alemtuzumab 10 MG/ML [Lemtrada] #1594660)

subject : Patient/pat1: Donald Duck "Donald DUCK"

authoredOn : 2015-01-15

requester : Practitioner/f007: Patrick Pump "Simone HEPS"

Reasons

- Concept
* Chronic Lymphoid Leukemia lymphoid leukemia, disease (disorder) ( SNOMED CT #92814006)

dosageInstruction

sequence : 1

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 12weeks , 3 per 1 weeks week

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)

DoseAndRates

- doseAndRate Type Dose[x]
* Ordered 3 mg (Details: UCUM codemg = 'mg')

dosageInstruction

sequence : 2

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 12weeks , 3 per 1 weeks week

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)

DoseAndRates

- doseAndRate Type Dose[x]
* Ordered 10 mg (Details: UCUM codemg = 'mg')

dosageInstruction

sequence : 3

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated () , Administer on alternate days ()

timing : Duration 12weeks, 12weeks , 3 per 1 weeks week

route : Intravenous route (qualifier value) ( SNOMED CT #47625008)

method : Inject - dosing instruction imperative (qualifier value) ( SNOMED CT #422145002)

DoseAndRates

- doseAndRate Type Dose[x]
* Ordered 30 mg (Details: UCUM codemg = 'mg')
  Other examples that reference this example:

Generated Narrative: Medication #med0303

MedicationAdministration/IV Admin Not Given MedicationDispense/IV Chemo

code : alemtuzumab 10 MG/ML [Lemtrada]

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.